BridgeMD
Prevention study for Constipation Drug Induced
Official title Prevention of Constipation in Cancer Patients
ClinicalTrials.gov ID: NCT07007468
What this study is testing
- What it's testing
- Constipation is the third most common symptom in patients undergoing chemotherapy, with an incidence rate ranging from 31% to 90%. Despite its high prevalence and adverse effects on patients, constipation is often not reported by patients and is not frequently monitored by nurses, resulting in delays in treatment and care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older,
- Receiving chemotherapy for breast cancer or lung cancer that causes constipation
- Patients who received at least one cycle of chemotherapy and experienced chemotherapy-associated constipation within five days of treatment (stool...
- Volunteers who are willing to participate in the research, can communicate, and can read and write,
- Without psychiatric illness and abdominal obstruction,
You likely can't join if
- Patients with stool type 3, 4, 5, 6 and 7 points according to the Bristol Stool Scale
See the full eligibility criteria
- 18 years of age or older,
- Receiving chemotherapy for breast cancer or lung cancer that causes constipation
- Patients who received at least one cycle of chemotherapy and experienced chemotherapy-associated constipation within five days of treatment (stool type 1 or 2 according to the Bristol Stool Scale)
- Volunteers who are willing to participate in the research, can communicate, and can read and write,
- Without psychiatric illness and abdominal obstruction,
- No mass in the abdominal region was detected,
- No intestinal bleeding,
- No history of radiation therapy to the abdominal region,
- No surgical procedures in the abdominal region,
- Patients without intra-abdominal infection, inflammatory bowel disease and irritable bowel syndrome will be included
- Patients with stool type 3, 4, 5, 6 and 7 points according to the Bristol Stool Scale
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Marmara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Marmara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.